A
ADIL
Azora Therapeutics Inc
3.900
-0.070-1.76%Closed16:00 10/09 EDT
OPEN/PREV CLOSE4.030/3.970
TODAY RANGE3.900-4.055
VOL3.05K
MARKET CAP10.24M
52 WEEK RANGE1.310-10.75
AVG VOL (3M)55.48K
% TURNOVER0.10%
TURNOVER--
P/E (TTM)-0.2353
% RANGE3.78%
EPS(TTM)-16.5720
P/E(FORWARD)-2.5828
P/B65.66
BVPS0.0594
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.52M
SHARES OUTSTANDING2.63M
NEXT EARNINGS11/11-11/16
FREE FLOAT2.44M
LOT SIZE1
EX-DATE02/06/2026
News
Press Releases
Financial Reports
Profile
TipRanks·10/02 20:51
Adial Pharmaceuticals Adjourns Meeting Pending Nasdaq Listing Decision
TipRanks·09/18 20:51
Adial Shareholders Approve Key Proposals, Meeting Adjourned
TipRanks·09/16 21:29
Adial Pharmaceuticals Amends Agreements to Restore Nasdaq Compliance
Benzinga·09/11 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·08/28 20:55
Adial Pharmaceuticals files to sell 25.15M shares of common stock for holders
TipRanks·08/25 20:57
Adial Pharmaceuticals Grants Inducement Stock Options to New Hire
Benzinga·08/24 17:06
12 Health Care Stocks Moving In Monday's Intraday Session
TipRanks·08/21 22:02
Adial Pharmaceuticals Faces Nasdaq Listing Compliance Challenge
Benzinga·08/17 12:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Seeking Alpha·08/17 11:04
Adial Pharmaceuticals GAAP EPS of -$11.25 misses by $8.60
Dow Jones·08/17 11:02
*Adial Pharmaceuticals 2Q Research and Development Expenses $440,000 >ADIL
Dow Jones·08/17 11:02
*Adial Pharmaceuticals 2Q Loss/Shr $11.25 >ADIL
Dow Jones·08/17 11:00
Press Release: Adial Pharmaceuticals Reports 2026 -2-